26 employees
Rubedo Life Sciences creates medicines to keep people biologically young by focusing on the pathologic cells that cause aging.
2018
$12M
from 4 investors over 4 rounds
Rubedo Life Sciences raised $12M on December 3, 2020
Investors: Shanda Group, The Longevity Fund, Refactor Capital and Khosla Ventures